Cancer Research Breakthroughs – Page 5 – NFCR

The Redux 3 file ReduxCore/inc/fields/typography/typography.php is still in use by Born to Give Child Theme. Please contact the author of this theme (NOT Redux support, we have no control over this issue). They need to update their project to use Redux 4 and discontinue use of this file. It will soon be removed from Redux.

Cancer Research Breakthroughs

Cancer May Metastasize Without Lymph Node Involvement

Cancer May Metastasize Without Lymph Node Involvement NFCR-funded research finds two distinct patterns of metastatic spread in human colorectal cancer (Bethesda, MD, July 13, 2017) Research by several leading scientists including Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and…...

Read more

FDA Approves First Cancer Drug Based on Genetics… Not Tumor Location

Just last week, the U.S. Food and Drug Administration approved the cancer medicine— Keytruda® (generic name pembrolizumab)— to treat cancers that have a specific genetic mutation or biomarker. This is the first time a cancer treatment has been approved based on a biomarker rather than the body location where the…...

Read more

Attacking Metastatic Tumors in the Brain

Targeting HER3 could cripple metastatic cancers that have spread to the brain. (Bethesda, MD, June 5, 2017) Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported by the National Foundation for Cancer Research, has discovered a novel mechanism behind…...

Read more

Non-Invasive Liquid Biopsy Uncovers Key Information to Treat Cancer

A liquid biopsy can provide valuable insight into how to best fight cancer. This noninvasive diagnostic is particularly helpful for patients who cannot undergo a surgical biopsy or whose tumor sample has been exhausted. In the not-too-distant future, liquid biopsies may be used to guide cancer treatment decisions and even…...

Read more

NFCR’s Genomics Newsroom: New genes linked to increased risk of ovarian and brain cancer

What is “genomics”? Cancer develops when genetic material (DNA) becomes damaged or changed. We know some cancer causing genetic changes are acquired (i.e. smoking), while others are inherited. Studying cancer genomics explores the differences between cancer cells and normal cells. Advances in understanding how cancer behaves at a genomic and…...

Read more

NFCR’s Genomics Newsroom: Using Molecular Imaging to Guide Cancer Therapy

Molecular imaging combines conventional anatomic imaging with genomic testing and enables doctors to literally see cancer at its molecular or genetic level....

Read more

New Treatment for Glioblastoma Multiforme Developed by NFCR Scientists

Dr. Web Cavenee and Dr. Paul B. Fisher discover a new pharmacological agent to treat glioblastoma multiforme (GBM), the deadliest brain cancer....

Read more

Genomic Testing Finds Link Between Breast and Bladder Cancer

Researchers from UNC, Chapel Hill found a subtype of bladder cancer has the same molecular signatures as a subset of breast cancer....

Read more

NFCR’s Genomics Newsroom: New Method to Detect Biomarkers

A method called MishCTC is being developed that will detect a molecular biomarker that is inside tumor cells but can’t be detected in normal blood cells....

Read more